Patent details

EP3226842 Title: ANTICANCER COMPOSITIONS

Basic Information

Publication number:
EP3226842
PCT Application Number:
US2015063667
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158176420
PCT Publication Number:
WO2016090101
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTICANCER COMPOSITIONS
French Title of Invention:
COMPOSITIONS ANTICANCÉREUSES
German Title of Invention:
ANTIKREBSZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
03/12/2015
Grant date:
25/11/2020
EP Publication Date:
11/10/2017
PCT Publication Date:
09/06/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/11/2020
EP B1 Publication Date:
25/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/12/2023
Expiration date:
03/12/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/12/2020
 
 

Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd, Suite 300, Los Angeles, CA 90024, United States (US)

History of Owners

From:
18/11/2020
To:
25/12/2020

Name:
Aragon Pharmaceuticals, Inc.
Address:
12780 El Camino Real, Suite 301, San Diego, CA 92130, United States (US)

Agent

Name:
ARONOVA S.A.
From:
21/01/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

Name:
VERRECK, Geert
Address:
Belgium (BE)

Priority

Priority Number:
14196591
Priority Date:
05/12/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/14; A61K 9/20; A61P 13/08; A61P 35/00; A61P 35/04;

Publication

European Patent Bulletin

1

Issue number:
202048
Publication date:
25/11/2020
Description:
Grant (B1)

2

Issue number:
202139
Publication date:
29/09/2021
Description:
Opposition procedure started

3

Issue number:
202517
Publication date:
23/04/2025
Description:
Opposition rejected; Patent maintained as granted

4

Issue number:
202053
Publication date:
30/12/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

5

Issue number:
202104
Publication date:
27/01/2021
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/11/2022
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
21/01/2021 Power Of Attorney 1
21/01/2021 Outgoing Correspondence 1